Kartik P.
About Kartik P.
Kartik P. serves as the Executive Director of Corporate Development at Mirum Pharmaceuticals, Inc., focusing on fostering collaboration among multidisciplinary teams to drive innovation in product development. He has extensive experience in the pharmaceutical industry, with previous roles at Onyx Pharmaceuticals, Merrimack Pharmaceuticals, Global Blood Therapeutics, and Graphite Bio.
Current Role at Mirum Pharmaceuticals
Kartik P. serves as the Executive Director of Corporate Development at Mirum Pharmaceuticals, Inc. since 2024. In this role, he focuses on building coalitions that unite multidisciplinary teams to foster innovation throughout all phases of product development. His leadership aims to enhance collaboration and drive advancements in therapeutic interventions.
Previous Experience in Pharmaceuticals
Kartik P. has held several significant positions in the pharmaceutical industry. He worked at Onyx Pharmaceuticals, a subsidiary of Amgen, as Manager of Pricing and Market Access from 2013 to 2015. He then joined Merrimack Pharmaceuticals as a Business Analyst from 2015 to 2017. Following this, he served as Director of Commercial Planning at Global Blood Therapeutics from 2017 to 2020. Most recently, he was the Senior Director of Program Team Leader at Graphite Bio from 2020 to 2022.
Education and Expertise
Kartik P. has a strong academic background in the life sciences and business. He earned a Doctor of Philosophy (PhD) in Developmental Biology from Baylor College of Medicine, completing his studies from 1999 to 2004. He furthered his education at the University of California, Berkeley, Haas School of Business, where he obtained a Master of Business Administration (M.B.A.) with a focus on Finance from 2012 to 2014. Additionally, he conducted post-doctoral research in Developmental Neuroscience at the Howard Hughes Medical Institute at UCLA from 2004 to 2012.
Focus on Patient Outcomes
Kartik P. is passionate about improving patient outcomes through innovative therapeutic interventions. His work in various roles across the pharmaceutical industry reflects a commitment to advancing healthcare solutions and enhancing the quality of life for patients.